1. Home
  2. XBIO vs IFBD Comparison

XBIO vs IFBD Comparison

Compare XBIO & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.69

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$0.94

Market Cap

7.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
IFBD
Founded
N/A
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.5M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
XBIO
IFBD
Price
$3.69
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.9K
6.9K
Earning Date
05-13-2026
05-01-2023
Dividend Yield
N/A
N/A
EPS Growth
38.52
N/A
EPS
N/A
N/A
Revenue
$2,976,411.00
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.04
N/A
52 Week Low
$1.90
$0.66
52 Week High
$13.93
$2.18

Technical Indicators

Market Signals
Indicator
XBIO
IFBD
Relative Strength Index (RSI) N/A 39.40
Support Level N/A $0.87
Resistance Level N/A $1.09
Average True Range (ATR) 0.00 0.08
MACD 0.00 -0.01
Stochastic Oscillator 0.00 39.52

Price Performance

Historical Comparison
XBIO
IFBD

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

Share on Social Networks: